Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2009 | Hbsag Clearance Continues to Increase Post-Treatment in Patients with Hcv Hbv Coinfection Treated with Peginterferon Alfa-2a Plus Ribavirin: 1.5 Year Follow-Up | LIU, CHUN-JEN; WU, SHUN-SHENG; CHAO, YOU- CHEN; YANG, SIEN-SING; LIN, CHIH-LIN; KAO, JIA-HORNG; LIU, CHEN-HUA; CHEN, PEI-JER; CHEN, DING-SHINN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN | HEPATOLOGY | | | |
2014 | Inosine Triphosphatase and Interleukin 28B Genetic Variants to Predict Sustained Virologic Response in Hemodialysis Patients with Hepatitis C Virus Genotype 1 or 2 Infection who Received Peginterferon alfa-2a plus Low-Dose Ribavirin: Data Analysis from HELPER-1 and HELPER-2 Trials | Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng | Hepatology | | | |
2008 | An Open-Label, Comparative, Multicentre Study of Peginterferon Alfa-2a ( 40kd) Plus Ribavirin in the Treatment of Patients Chronically Infected with Hcv/Hbv or Hcv Alone | LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; WU, SHUN-SHENG; LIAO, LI-YING; KUO, HSING-TAO; CHAO, YOU-CHEN; CHEN, CHI-LING; CHEN, PEI-JER; CHEN, DING-SHINN | JOURNAL OF HEPATOLOGY | | | |
2015 | Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; CHIH-HUNG LIN ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 8 | 8 | |
2015 | Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Huang, Jee-Fu; JOU-WEI LIN ; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; JIA-HORNG KAO ; Yu, Ming-Lung | Scientific reports | 7 | 7 | |
2013 | Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; HUNG-BIN TSAI ; MENG-KUN TSAI ; Chen, Shih-I; JOU-WEI LIN ; Yang, Sheng-Shun; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; Yu, Ming-Lung; JIA-HORNG KAO | Annals of internal medicine | 85 | 77 | |
1998 | PREVALENCE AND MANIFESTATIONS OF HEPATITIS C SEROPOSITIVITY IN CHILDREN IN AN ENDEMIC AREA | LU, SHENG-NAN; CHEN, HUI-CHI; WU, MEI-HUEI; YU, MING-LUNG; CHUANG, WAN-LONG; LU, CHIH-FENG; CHANG, WEN-YU; CHEN, CHIEN-JEN | PEDIATRIC INFECTIOUS DISEASE JOURNAL | | | |
2012 | Profiles and Clinical Significance of HBsAg Titer in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses | Liu, Chun-Jen; Yu, Ming-Lung; Lee, Chuan-Mo; Chen, Chi-Ling; Chuang, Wan-Long; Wu, Shun-Sheng; Yang, Sien-Sing; Kao, Jia-Horng; Lin, Chih-Lin; Chen, Pei-Jer; Chen, Ding-Shinn | Hepatology | | | |
2014 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2014 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2013 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng | Hepatology | | | |
2013 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng | Hepatology | | | |
2015 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2015 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2021 | Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C | SHIH-JER HSU ; Yu, Ming-Lung; Su, Chien-Wei; Peng, Cheng-Yuan; Chien, Rong-Nan; Lin, Hsien-Hong; Lo, Gin-Ho; Su, Wei-Wen; Kuo, Hsing-Tao; Hsu, Chao-Wei; Yang, Sien-Sing; Yang, Sheng-Shun; Tseng, Kuan-Chiao; Qin, Albert; Huang, Yi-Wen; Chuang, Wan-Long | Journal of the Formosan Medical Association = Taiwan yi zhi | 14 | 12 | |
2024 | Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection | Janssen, Harry L; Lim, Young-Suk; Kim, Hyung Joon; Sowah, Leonard; Tseng, Cheng-Hao; Coffin, Carla S; Elkhashab, Magdy; Ahn, Sang Hoon; Nguyen, Anh-Hoa; Chen, Diana; Wallin, Jeffrey J; Fletcher, Simon P; McDonald, Circe; Yang, Jenny C; Gaggar, Anuj; Brainard, Diana M; Fung, Scott; Kim, Yoon Jun; JIA-HORNG KAO ; Chuang, Wan-Long; Brooks, Anna E; Dunbar, P Rod | JHEP reports : innovation in hepatology | | | |
2014 | Significant Reduction of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Peg-interferon plus Ribavirin Therapy: A Five-year Clinical Cohort Study | Lee, Mei-Hsuan; Yuan, Yong; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Liu, Chen-Hua; Lu, Sheng-Nan; Sheen, I-Shyan; L'Italien, Gilbert J.; Yang, Hwai-I; Chen, Chien-Jen | Hepatology | | | |
2014 | Significant Reduction of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Peg-interferon plus Ribavirin Therapy: A Five-year Clinical Cohort Study | Lee, Mei-Hsuan; Yuan, Yong; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Liu, Chen-Hua; Lu, Sheng-Nan; Sheen, I-Shyan; L'Italien, Gilbert J.; Yang, Hwai-I; Chen, Chien-Jen | Hepatology | | | |